Press release
Parainfluenza Virus Infection Market: Insights on Epidemiology, Treatments, and Key Companies | Ansun Biopharma, AlloVir
Parainfluenza Virus Infection Market
Emerging therapies for Parainfluenza virus infection, including DAS181, ALVR106, and others, are expected to drive growth in the Parainfluenza virus infection market in the coming years.
DelveInsight has released a new report titled "Parainfluenza Virus Infection - Market Insights, Epidemiology, and Market Forecast-2034", offering a comprehensive analysis of the condition, covering historical and projected epidemiology as well as market trends across the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Discover about the Parainfluenza virus infection market report [https://www.delveinsight.com/report-store/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Some of the key facts of the Parainfluenza virus infection Market Report:
*
According to DelveInsight analysts, there were approximately 2,709,923 cases of Parainfluenza Virus (PIV) Infection across the 7MM in 2023, with the number expected to rise throughout the forecast period (2024-2034). In June 2024, researchers at Vanderbilt University Medical Center identified antibodies capable of blocking PIV infection, particularly human PIV type 3 (hPIV3), which is associated with severe respiratory illness in children and immunocompromised individuals. These discoveries may lead to the development of antibody-based therapies or vaccines in the future.
*
In 2023, the United States reported the highest number of PIV cases, followed by Japan, Spain, and Germany. The PIV drugs market in the 7MM was primarily composed of standard therapies, generating roughly USD 259 million in 2023. Overall, the PIV treatment market is expected to expand during the forecast period, driven by the increasing incidence of infections.
*
In the United States, DelveInsight estimated 1,456,399 PIV cases in 2023, with further growth anticipated. In the EU4 and the UK, there were approximately 991,115 cases, with Spain reporting the highest share and the UK the lowest. The therapeutics market for PIV is projected to grow steadily in the coming years.
*
The 7MM PIV drugs market totaled around USD 259 million in 2023, with strong projected growth through 2034. The U.S. accounted for 68% of the total market in 2023, followed by the EU4 and the UK, which together represented nearly 23% of the 7MM market. Japan held the second-largest market share, with approximately 262,409 cases in 2023, and is also expected to experience market expansion by 2034.
*
Key companies developing new therapies for PIV include Ansun Biopharma, AlloVir, and others. Promising investigational treatments in the pipeline include DAS181, ALVR106, and additional candidates aimed at improving the PIV treatment landscape.
Parainfluenza virus infection Overview
Parainfluenza virus (PIV) infection is a respiratory condition caused by one of four parainfluenza virus types: PIV-1, PIV-2, PIV-3, and PIV-4. These viruses belong to the Paramyxoviridae family and primarily affect the respiratory tract, leading to illnesses ranging from the common cold and croup to bronchiolitis and pneumonia. Transmission typically occurs through respiratory droplets expelled when an infected person coughs, sneezes, or talks, and it can also occur indirectly via contaminated surfaces.
Symptoms of PIV infection depend on the virus type and severity. Common signs resemble those of a cold, including runny nose, cough, sore throat, and fever. In more severe cases, symptoms may progress to difficulty breathing, wheezing, and chest discomfort.
Parainfluenza virus infection Market Outlook
Currently, the primary strategy for managing Parainfluenza Virus (PIV) infection is supportive care, except in cases of croup, where corticosteroids have proven beneficial. Investigational therapies, such as DAS181, show promise for severe infections in immunocompromised patients but are still in development. Despite ongoing research, effective treatment options remain limited, and there are no FDA-approved antiviral medications for PIV infection, leaving a significant unmet medical need.
Most PIV infections are self-limiting and resolve without specific treatment. Supportive measures-such as adequate rest, hydration, and over-the-counter symptom relief-are typically recommended. In severe cases or for patients with compromised immune systems, antiviral therapy or hospitalization may be necessary. Ribavirin is occasionally used off-label due to its in vitro activity against the virus, but its clinical effectiveness remains uncertain because of a lack of robust data from randomized controlled trials.
Discover how the Parainfluenza virus infection market is rising in the coming years @ https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Parainfluenza virus infection Emerging Drugs
*
DAS181: Ansun Biopharma
*
ALVR106: AlloVir
Scope of the Parainfluenza virus infection Market Report
*
Study Period: 2020-2034
*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
*
Key Parainfluenza virus infection Companies: Ansun Biopharma, AlloVir, and others
*
Key Parainfluenza virus infection Therapies: DAS181, ALVR106, and others
*
Parainfluenza virus infection Therapeutic Assessment: Parainfluenza virus infection current marketed and Parainfluenza virus infection emerging therapies
*
Parainfluenza virus infection Market Dynamics: Parainfluenza virus infection market drivers and Parainfluenza virus infection market barriers
*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies
*
Parainfluenza virus infection Unmet Needs, KOL's views, Analyst's views, Parainfluenza virus infection Market Access and Reimbursement
To know what's more in our Parainfluenza virus infection report, visit https://www.delveinsight.com/report-store/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Key benefits of the Parainfluenza virus infection Market Report:
*
Parainfluenza virus infection market report covers a descriptive overview and comprehensive insight of the Parainfluenza virus infection Epidemiology and Parainfluenza virus infection market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan).
*
The Parainfluenza virus infection market report provides insights into the current and emerging therapies.
*
The Parainfluenza virus infection market report provides a global historical and forecasted market covering drug outreach in 7MM.
*
The Parainfluenza virus infection market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Parainfluenza virus infection market.
Got queries? Click here to know more about the Parainfluenza virus infection market Landscape [https://www.delveinsight.com/sample-request/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Contents
1. Report Introduction
2. Executive Summary
3. SWOT analysis
4. Parainfluenza virus infection Patient Share (%) Overview at a Glance
5. Parainfluenza virus infection Market Overview at a Glance
6. Parainfluenza virus infection Disease Background and Overview
7. Parainfluenza virus infection Epidemiology and Patient Population
8. Country-Specific Patient Population of Parainfluenza virus infection
9. Parainfluenza virus infection Current Treatment and Medical Practices
10. Unmet Needs
11. Parainfluenza virus infection Emerging Therapies
12. Parainfluenza virus infection Market Outlook
13. Country-Wise Parainfluenza virus infection Market Analysis (2020-2034)
14. Market Access and Reimbursement of Therapies
15. Market drivers
16. Market barriers
17. Appendix
18. Parainfluenza virus infection Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
Click here to read more about Parainfluenza virus infection Market Outlook 2034 [https://www.delveinsight.com/report-store/parainfluenza-virus-infection-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Related Reports:
Parainfluenza virus infection Pipeline Insights, DelveInsight
"Parainfluenza virus infection Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Parainfluenza virus infection market. A detailed picture of the Parainfluenza virus infection pipeline landscape is provided, which includes the disease overview and Parainfluenza virus infection treatment guidelines.
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=parainfluenza-virus-infection-market-insights-on-epidemiology-treatments-and-key-companies-ansun-biopharma-allovir]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Parainfluenza Virus Infection Market: Insights on Epidemiology, Treatments, and Key Companies | Ansun Biopharma, AlloVir here
News-ID: 4187183 • Views: …
More Releases from ABNewswire
Dup15q Syndrome Market: Insights into Epidemiology, Treatments, and Key Companie …
Dup15q syndrome is a neurogenetic condition caused by duplications on chromosome 15q11.2-13.1. It is marked by hypotonia, developmental delays, intellectual disability (ID), epilepsy, and autism spectrum disorder (ASD). The extent of developmental impairments can vary significantly based on the nature of the duplication and whether it originated from the mother or father.
Emerging therapies for Dup15q syndrome, including Bexicaserin, UBE3A (ASO), and others, are anticipated to drive growth in the Dup15q…
Narcolepsy Market: Insights into Epidemiology, Treatment Landscape, and Key Play …
As per DelveInsight, the Narcolepsy Market is expected to expand at a healthy growth rate during the forecast period (2024-2034), owing to the launch of new therapies in the market and the rise in the number of cases.
Emerging therapies for narcolepsy, including AXS-12 (reboxetine) and others, are anticipated to drive significant growth in the narcolepsy market over the coming years.
DelveInsight has published a new report titled "Narcolepsy - Market Insights,…
Excessive Daytime Sleepiness (EDS) Market: Insights into Epidemiology, Treatment …
The total Excessive Daytime Sleepiness market size in the 7MM was approximately USD 6,227 million in 2023 and is projected to increase during the forecast period (2024-2034).
Emerging therapies for Excessive Daytime Sleepiness (EDS), including WAKIX (pitolisant), XYREM (sodium oxybate), XYWAV (a combination of calcium, magnesium, potassium, and sodium oxybates), among others, are anticipated to drive significant growth in the EDS market in the coming years.
DelveInsight has released a new report…
Nephrotic Syndrome Pipeline Drugs Insights Report 2025: Strategic Outlook on Cli …
DelveInsight's "Nephrotic Syndrome Pipeline Insight 2025" report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in the Nephrotic Syndrome pipeline landscape. It covers the Nephrotic Syndrome pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Nephrotic Syndrome pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Curious about the latest updates…
More Releases for Parainfluenza
Parainfluenza Virus Infection Market is expected to reach USD 1.15 billion by 20 …
Parainfluenza viruses (HPIVs) are a group of RNA viruses that cause respiratory tract infections, particularly in children, elderly patients, and immunocompromised individuals. HPIV infections are a leading cause of croup, bronchiolitis, and pneumonia, often requiring hospitalization in severe cases. Unlike influenza, there are currently no approved vaccines or specific antivirals for parainfluenza, making management largely supportive.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71751
Growing research in antivirals, monoclonal…
Parainfluenza virus infection Market: Epidemiology, Therapies, Companies, DelveI …
Parainfluenza virus infection therapies, such as DAS181, ALVR106, and others, are expected to boost the Parainfluenza virus infection Market in the upcoming years.
DelveInsight has launched a new report on "Parainfluenza virus infection - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Parainfluenza virus infection, historical and forecasted epidemiology as well as the Parainfluenza virus infection market trends in the United States, EU5 (Germany, Spain, Italy,…
Parainfluenza Virus Infection-Market Outlook report Assessment, Growth Trends, E …
It has been observed that, the global market for Parainfluenza Virus Infection-Market would be experiencing steady growth marked in million US$ by 2025. Such advancements can be attributed to the efforts put in by prime manufacturers operating in the global Parainfluenza Virus Infection-Market during the period 2028. All such statistics and figures are carefully enclosed in a recently uploaded research report titled “Parainfluenza Virus Infection-Market Insights, Epidemiology and Market” Forecast-2028,…
What's driving the Human Parainfluenza Viruses Diagnostics Market Size ? Qiagen, …
Market Study Report recently added a new report on Global Human Parainfluenza Viruses Diagnostics Market, which is an in-depth study providing complete analysis of the industry for the period 2018 to 2023. It provides complete overview of Global Human Parainfluenza Viruses Diagnostics industry considering all the major industry trends, market dynamics and competitive scenario.
The Human Parainfluenza Viruses Diagnostics market research report provides an in-depth analysis of the business space in…
Driving Innovation: Human Parainfluenza Viruses Diagnostics Market By Key Player …
Qyresearchreports include new market research report Human Parainfluenza Viruses Diagnostics to its huge collection of research reports.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
The human…
Human Parainfluenza Viruses Diagnostics Market will reach 940 million USD in 202 …
New report published by Global Info Research which offers insights on the global Human Parainfluenza Viruses Diagnostics market.
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
Click…
